Las Vegas, NV -- (SBWIRE) -- 01/04/2014 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Express, Inc.(NYSE:EXPR), TriQuint Semiconductor(NASDAQ:TQNT), Antares Pharma Inc(NASDAQ:ATRS), Cypress Semiconductor Corporation(NASDAQ:CY)
Express, Inc.(NYSE:EXPR) was a volume gainer of 2.18 million shares and the average volume of the stock remained 2.06 million shares. The stock opened the session at $18.63 and finished at the end of the day at $18.93 and the stock escalated 1.39%.The market capitalization of the stock remained 1.59 billion. Express, Inc. operates as a specialty apparel and accessory retailer primarily in the United States. Its stores provide apparel and accessories for women and men between 20 and 30 years old across various aspects of the lifestyles comprising work, casual, jeanswear, and going-out occasions.
For How Long EXPR will fight for Profitability? Read This Trend Analysis report
In the preceding trading session, TriQuint Semiconductor(NASDAQ:TQNT) exchanged 2.10 million shares and the average volume remained 1.73 million shares. The stock closed the session at $8.31 with the drop of -0.36%. TriQuint Semiconductor, Inc. provides radio frequency (RF) solutions and technology for mobile device, network infrastructure, and defense and aerospace markets worldwide. The company designs, develops, and manufactures an array of filtering, switching, and amplification products for RF, microwave, and millimeter-wave applications.
Why Should Investors Buy TQNT After the Recent Fall? Just Go Here and Find Out
Antares Pharma Inc(NASDAQ:ATRS) enhanced 1.54% and its closing price was $4.54. The volume of the stock was 2.08 million shares and the average volume remained 1.04 million shares. The market capitalization of the stock remained 579.36 million. The beta of the stock remained 0.14. Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide. The company was founded in 1979 and is headquartered in Ewing, New Jersey.
Why Should Investors Buy ATRS After The Recent Gain? Just Go Here and Find Out
Cypress Semiconductor Corporation(NASDAQ:CY) exchanged 2.03 million shares in the previous trading session, and its average trading remained 2.10 million shares. CY dropped -2.10% and it closed the trading at $10.28. The market capitalization of the stock remained 1.53 billion. Cypress Semiconductor Corporation, together with its subsidiaries, designs, develops, manufactures, and markets mixed-signal, programmable solutions, specialized semiconductor memories, and integrated semiconductor solutions. Cypress Semiconductor Corporation founded in 1982 and is headquartered in San Jose, California.
Has CY Found The Bottom and Ready To Move Up? Find Out Here
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)